Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase 1 3Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 15Recruiting 13Unknown 6Terminated 5Active not recruiting 4Withdrawn 3Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 72Lymphoid 68Other hematologic neoplasm 58Thoracic 45Breast 38Dermatologic 30Genitourinary 27CNS 25Gynecologic 23Myeloid 21Plasma cell 19Head & Neck 15Sarcoma 12Other solid neoplasm 10Tumor-Agnostic 4Endocrine 4NET 3Classical hematology 3Other 1

Conditions

Neuroendocrine Tumors 3Small Cell Lung Carcinoma 1Pheochromocytoma 1Paraganglioma 1Neoplasms 1Lung Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

lutetium Lu 177 dotatate 23-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Withdrawn × NET × Clear all
NCT04614766 2024-04-29

SPORE-3

University of Iowa

Phase 1/2 Withdrawn
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT03923257 2021-06-08

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

University of Iowa

Phase 1/2 Withdrawn
CNSEndocrineNET

Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

NCT02030184 2019-10-17

Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas

University of Maryland, Baltimore

Phase 1/2 Withdrawn
EndocrineNETThoracic

Lung Neoplasms, Neoplasms, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡